APO Research
Talk to an analyst

APO RESEARCH · REPORT

Tumor Ablation

This is a minimally invasive surgical method to treat solid cancers, Special probes are used to “burn” or “freeze” cancers without the usual surgery. Computed Tomography (CT), Ultrasound (US) or Magnetic Resonance Imaging (MRI) is used to guide and position the needle probe into the tumor. This requires only a tiny hole, usually less than 3 mm via which the probe is introduced. When the probe is within the cancer it is attached to a generator which “burns” or “freezes” the cancer. In this report, we only study the Tumor Ablation devices without Consumables.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

This is a minimally invasive surgical method to treat solid cancers, Special probes are used to “burn” or “freeze” cancers without the usual surgery. Computed Tomography (CT), Ultrasound (US) or Magnetic Resonance Imaging (MRI) is used to guide and position the needle probe into the tumor. This requires only a tiny hole, usually less than 3 mm via which the probe is introduced. When the probe is within the cancer it is attached to a generator which “burns” or “freezes” the cancer. In this report, we only study the Tumor Ablation devices without Consumables.

Selected research

Market Outlook & Growth Opportunities

Global Tumor Ablation Market Outlook and Growth Opportunities 2026

1 January 2026198 pages

Choose your research edition.

Industry ResearchTumor Ablation Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Tumor Ablation Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Tumor Ablation Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Tumor Ablation Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Tumor Ablation Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

This is a minimally invasive surgical method to treat solid cancers, Special probes are used to “burn” or “freeze” cancers without the usual surgery. Computed Tomography (CT), Ultrasound (US) or Magnetic Resonance Imaging (MRI) is used to guide and position the needle probe into the tumor. This requires only a tiny hole, usually less than 3 mm via which the probe is introduced. When the probe is within the cancer it is attached to a generator which “burns” or “freezes” the cancer. In this report, we only study the Tumor Ablation devices without Consumables.

Global Tumor Ablation key players include Chongqing Haifu Medical, HealthTronics, AngioDynamics, Boston Scientific, Medtronic, etc. Global top five manufacturers hold a share about 55%.

North America is the largest market, with a share about 40%, followed by Europe, with a share about 30 percent. In terms of product, Radiofrequency (RF) Ablation is the largest segment, with a share about 40%. And in terms of application, the largest application is Lung Cancer, followed by Liver Cancer, Kidney Cancer, etc.

Read the full market overview

This report provides an overview of the global Tumor Ablation market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Tumor Ablation and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Tumor Ablation sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Tumor Ablation market size, projected growth trends, production technologies, key applications, and end-use industries.

Tumor Ablation Segment by Company

Angiodynamics

Medtronic

Boston Scientific

Misonix

Sonacare Medical

EDAP TMS

Chongqing Haifu Medical

HealthTronics

J &J

Tumor Ablation Segment by Type

Radiofrequency (RF) Ablation

Microwave Ablation

Cryoablation

Other Technologies

Tumor Ablation Segment by Application

Liver Cancer

Lung Cancer

Kidney Cancer

Others

Tumor Ablation Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Tumor Ablation status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Tumor Ablation market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Tumor Ablation significant trends, drivers, influence factors in global and regions.

6. To analyze Tumor Ablation competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tumor Ablation market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Tumor Ablation and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tumor Ablation.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Tumor Ablation market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Tumor Ablation industry.

Chapter 3: Detailed analysis of Tumor Ablation manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Tumor Ablation in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Tumor Ablation in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Tumor Ablation Industry Trends Table 2. Tumor Ablation Industry Drivers Table 3. Tumor Ablation Industry Opportunities and Challenges Table 4. Tumor Ablation Industry Restraints Table 5. Global Tumor Ablation Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Tumor Ablation Revenue Share by Company (2021-2026) Table 7. Global Tumor Ablation Sales Volume by Company (Units) & (2021-2026) Table 8. Global Tumor Ablation Sales Volume Share by Company (2021-2026) Table 9. Global Tumor Ablation Average Price (USD/Unit) of Company (2021-2026) Table 10. Global Tumor Ablation Company Ranking, (2024-2026) & (USD Million) Table 11. Global Tumor Ablation Key Company Manufacturing Base & Headquarters Table 12. Global Tumor Ablation Company, Product Type & Application Table 13. Global Tumor Ablation Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Tumor Ablation by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Radiofrequency (RF) Ablation Table 18. Significant Companies of Microwave Ablation Table 19. Significant Companies of Cryoablation Table 20. Significant Companies of Other Technologies Table 21. Global Tumor Ablation Sales Volume by Type 2021 VS 2025 VS 2032 (Units) Table 22. Global Tumor Ablation Sales Volume by Type (2021-2026) & (Units) Table 23. Global Tumor Ablation Sales Volume by Type (2027-2032) & (Units) Table 24. Global Tumor Ablation Sales Volume Share by Type (2021-2026) Table 25. Global Tumor Ablation Sales Volume Share by Type (2027-2032) Table 26. Global Tumor Ablation Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Tumor Ablation Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Tumor Ablation Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Tumor Ablation Sales Value Share by Type (2021-2026) Table 30. Global Tumor Ablation Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Liver Cancer Table 32. Significant Companies of Lung Cancer Table 33. Significant Companies of Kidney Cancer Table 34. Significant Companies of Others Table 35. Global Tumor Ablation Sales Volume by Application 2021 VS 2025 VS 2032 (Units) Table 36. Global Tumor Ablation Sales Volume by Application (2021-2026) & (Units) Table 37. Global Tumor Ablation Sales Volume by Application (2027-2032) & (Units) Table 38. Global Tumor Ablation Sales Volume Share by Application (2021-2026) Table 39. Global Tumor Ablation Sales Volume Share by Application (2027-2032) Table 40. Global Tumor Ablation Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global Tumor Ablation Sales Value by Application (2021-2026) & (US$ Million) Table 42. Global Tumor Ablation Sales Value by Application (2027-2032) & (US$ Million) Table 43. Global Tumor Ablation Sales Value Share by Application (2021-2026) Table 44. Global Tumor Ablation Sales Value Share by Application (2027-2032) Table 45. Global Tumor Ablation Sales by Region: 2021 VS 2025 VS 2032 (Units) Table 46. Global Tumor Ablation Sales by Region (2021-2026) & (Units) Table 47. Global Tumor Ablation Sales Market Share by Region (2021-2026) Table 48. Global Tumor Ablation Sales by Region (2027-2032) & (Units) Table 49. Global Tumor Ablation Sales Market Share by Region (2027-2032) Table 50. Global Tumor Ablation Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Tumor Ablation Sales Value by Region (2021-2026) & (US$ Million) Table 52. Global Tumor Ablation Sales Value Share by Region (2021-2026) Table 53. Global Tumor Ablation Sales Value by Region (2027-2032) & (US$ Million) Table 54. Global Tumor Ablation Sales Value Share by Region (2027-2032) Table 55. Global Tumor Ablation Market Average Price (USD/Unit) by Region (2021-2026) Table 56. Global Tumor Ablation Market Average Price (USD/Unit) by Region (2027-2032) Table 57. Global Tumor Ablation Sales by Country: 2021 VS 2025 VS 2032 (Units) Table 58. Global Tumor Ablation Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Tumor Ablation Sales by Country (2021-2026) & (Units) Table 60. Global Tumor Ablation Sales Market Share by Country (2021-2026) Table 61. Global Tumor Ablation Sales by Country (2027-2032) & (Units) Table 62. Global Tumor Ablation Sales Market Share by Country (2027-2032) Table 63. Global Tumor Ablation Sales Value by Country (2021-2026) & (US$ Million) Table 64. Global Tumor Ablation Sales Value Market Share by Country (2021-2026) Table 65. Global Tumor Ablation Sales Value by Country (2027-2032) & (US$ Million) Table 66. Global Tumor Ablation Sales Value Market Share by Country (2027-2032) Table 67. Angiodynamics Company Information Table 68. Angiodynamics Business Overview Table 69. Angiodynamics Tumor Ablation Sales (Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 70. Angiodynamics Tumor Ablation Product Portfolio Table 71. Angiodynamics Recent Development Table 72. Medtronic Company Information Table 73. Medtronic Business Overview Table 74. Medtronic Tumor Ablation Sales (Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 75. Medtronic Tumor Ablation Product Portfolio Table 76. Medtronic Recent Development Table 77. Boston Scientific Company Information Table 78. Boston Scientific Business Overview Table 79. Boston Scientific Tumor Ablation Sales (Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 80. Boston Scientific Tumor Ablation Product Portfolio Table 81. Boston Scientific Recent Development Table 82. Misonix Company Information Table 83. Misonix Business Overview Table 84. Misonix Tumor Ablation Sales (Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 85. Misonix Tumor Ablation Product Portfolio Table 86. Misonix Recent Development Table 87. Sonacare Medical Company Information Table 88. Sonacare Medical Business Overview Table 89. Sonacare Medical Tumor Ablation Sales (Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 90. Sonacare Medical Tumor Ablation Product Portfolio Table 91. Sonacare Medical Recent Development Table 92. EDAP TMS Company Information Table 93. EDAP TMS Business Overview Table 94. EDAP TMS Tumor Ablation Sales (Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 95. EDAP TMS Tumor Ablation Product Portfolio Table 96. EDAP TMS Recent Development Table 97. Chongqing Haifu Medical Company Information Table 98. Chongqing Haifu Medical Business Overview Table 99. Chongqing Haifu Medical Tumor Ablation Sales (Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 100. Chongqing Haifu Medical Tumor Ablation Product Portfolio Table 101. Chongqing Haifu Medical Recent Development Table 102. HealthTronics Company Information Table 103. HealthTronics Business Overview Table 104. HealthTronics Tumor Ablation Sales (Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 105. HealthTronics Tumor Ablation Product Portfolio Table 106. HealthTronics Recent Development Table 107. J &J Company Information Table 108. J &J Business Overview Table 109. J &J Tumor Ablation Sales (Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 110. J &J Tumor Ablation Product Portfolio Table 111. J &J Recent Development Table 112. Key Raw Materials Table 113. Raw Materials Key Suppliers Table 114. Tumor Ablation Distributors List Table 115. Tumor Ablation Customers List Table 116. Research Programs/Design for This Report Table 117. Authors List of This Report Table 118. Secondary Sources Table 119. Primary Sources List of Figures Figure 1. Tumor Ablation Product Image Figure 2. Global Tumor Ablation Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Tumor Ablation Sales Value (2021-2032) & (US$ Million) Figure 4. Global Tumor Ablation Sales (2021-2032) & (Units) Figure 5. Global Tumor Ablation Sales Average Price (USD/Unit) & (2021-2032) Figure 6. Global Tumor Ablation Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Radiofrequency (RF) Ablation Image Figure 10. Microwave Ablation Image Figure 11. Cryoablation Image Figure 12. Other Technologies Image Figure 13. Global Tumor Ablation Sales Volume by Type (2021 VS 2025 VS 2032) & (Units) Figure 14. Global Tumor Ablation Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Tumor Ablation Sales Volume Share by Type (2021-2032) Figure 16. Global Tumor Ablation Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Tumor Ablation Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Tumor Ablation Sales Value Share by Type (2021-2032) Figure 19. Liver Cancer Image Figure 20. Lung Cancer Image Figure 21. Kidney Cancer Image Figure 22. Others Image Figure 23. Global Tumor Ablation Sales Volume by Application (2021 VS 2025 VS 2032) & (Units) Figure 24. Global Tumor Ablation Sales Volume Share 2021 VS 2025 VS 2032 Figure 25. Global Tumor Ablation Sales Volume Share by Application (2021-2032) Figure 26. Global Tumor Ablation Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Tumor Ablation Sales Value Share 2021 VS 2025 VS 2032 Figure 28. Global Tumor Ablation Sales Value Share by Application (2021-2032) Figure 29. Global Tumor Ablation Sales by Region: 2021 VS 2025 VS 2032 (Units) Figure 30. Global Tumor Ablation Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 31. Global Tumor Ablation Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 32. Global Tumor Ablation Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 33. North America Tumor Ablation Sales Value (2021-2032) & (US$ Million) Figure 34. North America Tumor Ablation Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Europe Tumor Ablation Sales Value (2021-2032) & (US$ Million) Figure 36. Europe Tumor Ablation Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Asia-Pacific Tumor Ablation Sales Value (2021-2032) & (US$ Million) Figure 38. Asia-Pacific Tumor Ablation Sales Value Share by Country (%), 2025 VS 2032 Figure 39. South America Tumor Ablation Sales Value (2021-2032) & (US$ Million) Figure 40. South America Tumor Ablation Sales Value Share by Country (%), 2025 VS 2032 Figure 41. Middle East & Africa Tumor Ablation Sales Value (2021-2032) & (US$ Million) Figure 42. Middle East & Africa Tumor Ablation Sales Value Share by Country (%), 2025 VS 2032 Figure 43. USA Tumor Ablation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. USA Tumor Ablation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. USA Tumor Ablation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Canada Tumor Ablation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Canada Tumor Ablation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Canada Tumor Ablation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Mexico Tumor Ablation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Mexico Tumor Ablation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Mexico Tumor Ablation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Germany Tumor Ablation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Germany Tumor Ablation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Germany Tumor Ablation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. France Tumor Ablation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. France Tumor Ablation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. France Tumor Ablation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. U.K. Tumor Ablation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. U.K. Tumor Ablation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. U.K. Tumor Ablation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Italy Tumor Ablation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Italy Tumor Ablation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Italy Tumor Ablation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Spain Tumor Ablation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Spain Tumor Ablation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Spain Tumor Ablation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Russia Tumor Ablation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Russia Tumor Ablation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Russia Tumor Ablation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Netherlands Tumor Ablation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Netherlands Tumor Ablation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Netherlands Tumor Ablation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Nordic Countries Tumor Ablation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Nordic Countries Tumor Ablation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Nordic Countries Tumor Ablation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. China Tumor Ablation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. China Tumor Ablation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. China Tumor Ablation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Japan Tumor Ablation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Japan Tumor Ablation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Japan Tumor Ablation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. South Korea Tumor Ablation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. South Korea Tumor Ablation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. South Korea Tumor Ablation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. India Tumor Ablation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. India Tumor Ablation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. India Tumor Ablation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Australia Tumor Ablation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Australia Tumor Ablation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Australia Tumor Ablation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Southeast Asia Tumor Ablation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Southeast Asia Tumor Ablation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Southeast Asia Tumor Ablation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Brazil Tumor Ablation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Brazil Tumor Ablation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Brazil Tumor Ablation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Argentina Tumor Ablation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Argentina Tumor Ablation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Argentina Tumor Ablation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Chile Tumor Ablation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Chile Tumor Ablation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Chile Tumor Ablation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Colombia Tumor Ablation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Colombia Tumor Ablation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Colombia Tumor Ablation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Peru Tumor Ablation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Peru Tumor Ablation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Peru Tumor Ablation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Tumor Ablation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Saudi Arabia Tumor Ablation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Tumor Ablation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Israel Tumor Ablation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Israel Arabia Tumor Ablation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Israel Arabia Tumor Ablation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. UAE Tumor Ablation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. UAE Tumor Ablation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. UAE Tumor Ablation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Turkey Tumor Ablation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Turkey Tumor Ablation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Turkey Tumor Ablation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Iran Tumor Ablation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Iran Tumor Ablation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Iran Tumor Ablation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Egypt Tumor Ablation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 125. Egypt Tumor Ablation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 126. Egypt Tumor Ablation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 127. Tumor Ablation Value Chain Figure 128. Manufacturing Cost Structure Figure 129. Tumor Ablation Sales Mode & Process Figure 130. Direct Comparison with Distribution Share Figure 131. Distributors Profiles Figure 132. Years Considered Figure 133. Research Process Figure 134. Key Executives Interviewed

Scope & coverage.

Types
  • Radiofrequency (RF) Ablation
  • Microwave Ablation
  • Cryoablation
  • Other Technologies
Applications
  • Liver Cancer
  • Lung Cancer
  • Kidney Cancer
  • Others
Companies covered
  • Angiodynamics
  • Medtronic
  • Boston Scientific
  • Misonix
  • Sonacare Medical
  • EDAP TMS
  • Chongqing Haifu Medical
  • HealthTronics
  • J &J

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Tumor Ablation Sales Value (2021-2032)
  4. 1.2.2 Global Tumor Ablation Sales Volume (2021-2032)
  5. 1.2.3 Global Tumor Ablation Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Tumor Ablation Market Dynamics
  1. 2.1 Tumor Ablation Industry Trends
  2. 2.2 Tumor Ablation Industry Drivers
  3. 2.3 Tumor Ablation Industry Opportunities and Challenges
  4. 2.4 Tumor Ablation Industry Restraints
3 Tumor Ablation Market by Company
  1. 3.1 Global Tumor Ablation Company Revenue Ranking in 2025
  2. 3.2 Global Tumor Ablation Revenue by Company (2021-2026)
  3. 3.3 Global Tumor Ablation Sales Volume by Company (2021-2026)
  4. 3.4 Global Tumor Ablation Average Price by Company (2021-2026)
  5. 3.5 Global Tumor Ablation Company Ranking (2024-2026)
  6. 3.6 Global Tumor Ablation Company Manufacturing Base and Headquarters
  7. 3.7 Global Tumor Ablation Company Product Type and Application
  8. 3.8 Global Tumor Ablation Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Tumor Ablation Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Tumor Ablation Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Tumor Ablation Market by Type
  1. 4.1 Tumor Ablation Type Introduction
  2. 4.1.1 Radiofrequency (RF) Ablation
  3. 4.1.2 Microwave Ablation
  4. 4.1.3 Cryoablation
  5. 4.1.4 Other Technologies
  6. 4.2 Global Tumor Ablation Sales Volume by Type
  7. 4.2.1 Global Tumor Ablation Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Tumor Ablation Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Tumor Ablation Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Tumor Ablation Sales Value by Type
  11. 4.3.1 Global Tumor Ablation Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Tumor Ablation Sales Value by Type (2021-2032)
  13. 4.3.3 Global Tumor Ablation Sales Value Share by Type (2021-2032)
5 Tumor Ablation Market by Application
  1. 5.1 Tumor Ablation Application Introduction
  2. 5.1.1 Liver Cancer
  3. 5.1.2 Lung Cancer
  4. 5.1.3 Kidney Cancer
  5. 5.1.4 Others
  6. 5.2 Global Tumor Ablation Sales Volume by Application
  7. 5.2.1 Global Tumor Ablation Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Tumor Ablation Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Tumor Ablation Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Tumor Ablation Sales Value by Application
  11. 5.3.1 Global Tumor Ablation Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Tumor Ablation Sales Value by Application (2021-2032)
  13. 5.3.3 Global Tumor Ablation Sales Value Share by Application (2021-2032)
6 Tumor Ablation Regional Sales and Value Analysis
  1. 6.1 Global Tumor Ablation Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Tumor Ablation Sales by Region (2021-2032)
  3. 6.2.1 Global Tumor Ablation Sales by Region: 2021-2026
  4. 6.2.2 Global Tumor Ablation Sales by Region (2027-2032)
  5. 6.3 Global Tumor Ablation Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Tumor Ablation Sales Value by Region (2021-2032)
  7. 6.4.1 Global Tumor Ablation Sales Value by Region: 2021-2026
  8. 6.4.2 Global Tumor Ablation Sales Value by Region (2027-2032)
  9. 6.5 Global Tumor Ablation Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Tumor Ablation Sales Value (2021-2032)
  12. 6.6.2 North America Tumor Ablation Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Tumor Ablation Sales Value (2021-2032)
  15. 6.7.2 Europe Tumor Ablation Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Tumor Ablation Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Tumor Ablation Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Tumor Ablation Sales Value (2021-2032)
  21. 6.9.2 South America Tumor Ablation Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Tumor Ablation Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Tumor Ablation Sales Value Share by Country, 2025 VS 2032
7 Tumor Ablation Country-level Sales and Value Analysis
  1. 7.1 Global Tumor Ablation Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Tumor Ablation Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Tumor Ablation Sales by Country (2021-2032)
  4. 7.3.1 Global Tumor Ablation Sales by Country (2021-2026)
  5. 7.3.2 Global Tumor Ablation Sales by Country (2027-2032)
  6. 7.4 Global Tumor Ablation Sales Value by Country (2021-2032)
  7. 7.4.1 Global Tumor Ablation Sales Value by Country (2021-2026)
  8. 7.4.2 Global Tumor Ablation Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Tumor Ablation Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Tumor Ablation Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Tumor Ablation Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Tumor Ablation Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Tumor Ablation Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Tumor Ablation Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Tumor Ablation Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Tumor Ablation Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Tumor Ablation Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Tumor Ablation Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Tumor Ablation Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Tumor Ablation Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Tumor Ablation Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Tumor Ablation Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Tumor Ablation Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Tumor Ablation Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Tumor Ablation Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Tumor Ablation Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Tumor Ablation Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Tumor Ablation Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Tumor Ablation Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Tumor Ablation Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Tumor Ablation Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Tumor Ablation Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Tumor Ablation Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Tumor Ablation Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Tumor Ablation Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Tumor Ablation Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Tumor Ablation Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Tumor Ablation Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Tumor Ablation Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Tumor Ablation Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Tumor Ablation Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Tumor Ablation Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Tumor Ablation Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Tumor Ablation Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Tumor Ablation Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Tumor Ablation Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Tumor Ablation Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Tumor Ablation Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Tumor Ablation Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Tumor Ablation Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Tumor Ablation Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Tumor Ablation Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Tumor Ablation Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Tumor Ablation Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Tumor Ablation Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Tumor Ablation Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Tumor Ablation Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Tumor Ablation Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Tumor Ablation Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Tumor Ablation Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Tumor Ablation Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Tumor Ablation Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Tumor Ablation Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Tumor Ablation Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Tumor Ablation Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Tumor Ablation Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Tumor Ablation Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Tumor Ablation Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Tumor Ablation Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Tumor Ablation Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Tumor Ablation Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Tumor Ablation Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Tumor Ablation Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Tumor Ablation Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Tumor Ablation Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Tumor Ablation Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Tumor Ablation Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Tumor Ablation Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Tumor Ablation Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Tumor Ablation Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Tumor Ablation Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Tumor Ablation Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Tumor Ablation Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Tumor Ablation Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Tumor Ablation Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Tumor Ablation Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Tumor Ablation Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Tumor Ablation Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Tumor Ablation Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Tumor Ablation Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Tumor Ablation Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Tumor Ablation Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Angiodynamics
  2. 8.1.1 Angiodynamics Company Information
  3. 8.1.2 Angiodynamics Business Overview
  4. 8.1.3 Angiodynamics Tumor Ablation Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Angiodynamics Tumor Ablation Product Portfolio
  6. 8.1.5 Angiodynamics Recent Developments
  7. 8.2 Medtronic
  8. 8.2.1 Medtronic Company Information
  9. 8.2.2 Medtronic Business Overview
  10. 8.2.3 Medtronic Tumor Ablation Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Medtronic Tumor Ablation Product Portfolio
  12. 8.2.5 Medtronic Recent Developments
  13. 8.3 Boston Scientific
  14. 8.3.1 Boston Scientific Company Information
  15. 8.3.2 Boston Scientific Business Overview
  16. 8.3.3 Boston Scientific Tumor Ablation Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Boston Scientific Tumor Ablation Product Portfolio
  18. 8.3.5 Boston Scientific Recent Developments
  19. 8.4 Misonix
  20. 8.4.1 Misonix Company Information
  21. 8.4.2 Misonix Business Overview
  22. 8.4.3 Misonix Tumor Ablation Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Misonix Tumor Ablation Product Portfolio
  24. 8.4.5 Misonix Recent Developments
  25. 8.5 Sonacare Medical
  26. 8.5.1 Sonacare Medical Company Information
  27. 8.5.2 Sonacare Medical Business Overview
  28. 8.5.3 Sonacare Medical Tumor Ablation Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Sonacare Medical Tumor Ablation Product Portfolio
  30. 8.5.5 Sonacare Medical Recent Developments
  31. 8.6 EDAP TMS
  32. 8.6.1 EDAP TMS Company Information
  33. 8.6.2 EDAP TMS Business Overview
  34. 8.6.3 EDAP TMS Tumor Ablation Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 EDAP TMS Tumor Ablation Product Portfolio
  36. 8.6.5 EDAP TMS Recent Developments
  37. 8.7 Chongqing Haifu Medical
  38. 8.7.1 Chongqing Haifu Medical Company Information
  39. 8.7.2 Chongqing Haifu Medical Business Overview
  40. 8.7.3 Chongqing Haifu Medical Tumor Ablation Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Chongqing Haifu Medical Tumor Ablation Product Portfolio
  42. 8.7.5 Chongqing Haifu Medical Recent Developments
  43. 8.8 HealthTronics
  44. 8.8.1 HealthTronics Company Information
  45. 8.8.2 HealthTronics Business Overview
  46. 8.8.3 HealthTronics Tumor Ablation Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 HealthTronics Tumor Ablation Product Portfolio
  48. 8.8.5 HealthTronics Recent Developments
  49. 8.9 J &J
  50. 8.9.1 J &J Company Information
  51. 8.9.2 J &J Business Overview
  52. 8.9.3 J &J Tumor Ablation Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 J &J Tumor Ablation Product Portfolio
  54. 8.9.5 J &J Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Tumor Ablation Value Chain Analysis
  2. 9.1.1 Tumor Ablation Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Tumor Ablation Sales Mode & Process
  6. 9.2 Tumor Ablation Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Tumor Ablation Distributors
  9. 9.2.3 Tumor Ablation Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst